iNtRON Biotechnology Inc (048530)

KOSDAQ
Currency in KRW
5,280
+20(+0.38%)
Closed

048530 Income Statement

Advanced Income Statement
Period Ending:
2012
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa8,347.4645,433.1629,308.0114,006.989,585.44
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-59.45%+444.28%-35.49%-52.21%-31.57%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4,645.0418,982.17,613.84,411.543,802.39
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa3,702.4226,451.0621,694.219,595.435,783.05
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-75.43%+614.43%-17.98%-55.77%-39.73%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa44.35%58.22%74.02%68.5%60.33%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa8,070.510,714.8411,616.7211,074.559,068.01
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-18.51%+32.77%+8.42%-4.67%-18.12%
aa.aaaa.aaaa.aaaa.aaaa.aa2,252.53,488.93,553.293,312.093,173.66
aa.aaaa.aaaa.aaaa.aaaa.aa4,836.466,192.467,042.686,795.614,946.21
aa.aaaa.aaaa.aaaa.aaaa.aa304.1280.48317.09270.75212.56
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-4,368.0815,736.2210,077.49-1,479.12-3,284.96
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-184.56%+460.26%-35.96%-114.68%-122.09%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-52.33%34.64%34.38%-10.56%-34.27%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-147.32-435.18-1,129.2-1,791.76-45.27
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-301.05%-195.4%-159.48%-58.68%+97.47%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-957.13-1,184.13-1,636.33-3,505.9-2,918.92
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa809.81748.95507.131,714.132,873.65
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa2,902.66426.991,229.3612,802.03228.75
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-1,612.7415,728.0310,177.649,531.15-3,101.49
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-23.7463.53-46.75-70.586.08
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa122.93172.27---5,755.96
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-1,914.5517,051.1110,574.838,318.77-10,836.89
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-126.18%+990.61%-37.98%-21.33%-230.27%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-22.94%37.53%36.08%59.39%-113.06%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,273.012,103.14846.812,606.86-1,141.48
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-3,187.5614,947.979,728.025,711.91-9,695.41
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa0.42----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-3,187.1414,947.979,728.025,711.91-9,695.41
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-136.59%+569.01%-34.92%-41.28%-269.74%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-38.18%32.9%33.19%40.78%-101.15%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-3,187.1414,947.979,728.025,711.91-9,695.41
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-106.43454.94288.42168.38-292.11
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-136.59%+527.44%-36.6%-41.62%-273.48%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-170.5389.09288-0.34-292.11
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-159.38%+328.21%-25.98%-100.12%-85,814.25%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa29.9432.8633.7333.9233.19
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa33.2635.2833.7333.9233.19
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa----100
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-2,944.5217,305.3411,613.9887.7-1,373.3
EBITDA Growth
aa.aaaa.aa